跳轉至內容
Merck
  • Homozygous recessive MYH2 mutation mimicking dominant MYH2 associated myopathy.

Homozygous recessive MYH2 mutation mimicking dominant MYH2 associated myopathy.

Neuromuscular disorders : NMD (2018-06-24)
Andrew R Findlay, Matthew B Harms, Alan Pestronk, Conrad C Weihl
摘要

Mutations in MYH2 that encodes myosin heavy chain IIa cause both dominant and recessively inherited myopathies. Patients with dominantly inherited MYH2 missense mutations present with ophthalmoplegia and progressive proximal limb weakness. Muscle biopsy reveals rimmed vacuoles and inclusions, prompting this entity to initially be described as hereditary inclusion body myopathy 3. In contrast, patients with recessive MYH2 mutations have early onset, non-progressive, diffuse weakness and ophthalmoplegia. Muscle biopsy reveals near or complete absence of type 2A fibers with no vacuole or inclusion pathology. We describe a patient with childhood onset ophthalmoplegia, progressive proximal muscle weakness beginning in adolescence, and muscle biopsy with myopathic changes and rimmed vacuoles. Although this patient's disease course and histopathology is consistent with dominant MYH2 mutations, whole exome sequencing revealed a c.737 G>A p.Arg246His homozygous MYH2 variant. These findings expand the clinical and pathologic phenotype of recessive MYH2 myopathies.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
抗IV型胶原抗体, Chemicon®, from rabbit